Nectar Lifesci.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE023H01027
  • NSEID: NECLIFE
  • BSEID: 532649
INR
9.90
-0.08 (-0.8%)
BSENSE

Nov 20

BSE+NSE Vol: 1.93 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 216478,
    "name": "Nectar Lifesci.",
    "stock_name": "Nectar Lifesci.",
    "full_name": "Nectar Lifescience Ltd",
    "name_url": "stocks-analysis/nectar-lifesci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.90",
    "chg": -0.08,
    "chgp": "-0.8%",
    "dir": -1,
    "prev_price": "9.98",
    "mcapval": "198.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532649,
    "symbol": "NECLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE023H01027",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "1.93 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/nectar-lifesci-216478-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Nectar Lifescience Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/nectar-lifescience-ltd-is-rated-strong-sell-4266786",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NectarLifescien_mojoScore_4266786.png",
        "date": "2026-11-18 10:11:06",
        "description": "Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Nectar Lifescience Ltd Reports Negative Financial Trend Amidst Mixed Quarterly Performance",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nectar-lifescience-ltd-reports-negative-financial-trend-amidst-mixed-quarterly-performance-4265448",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/NectarLifescien_fintrenddot_4265448.png",
        "date": "2026-11-17 11:00:06",
        "description": "Nectar Lifescience Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a marked deterioration in its financial trend for the quarter ended September 2026. Despite posting its highest quarterly PAT in recent history, the company’s overall financial health has weakened, with key profitability and efficiency metrics showing significant contraction compared to historical averages."
      },
      {
        "title": "Nectar Lifescience Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nectar-lifescience-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4245007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NectarLifescien_stocks_hitting_lower_circuit_4245007.png",
        "date": "2026-10-30 14:00:08",
        "description": "At Rs 9.82, sellers were still queuing — but there were no buyers willing to take the other side. Nectar Lifescience Ltd locked at its lower circuit of 5% on 29 Oct 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand."
      },
      {
        "title": "Nectar Lifescience Ltd Falls 2.09%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nectar-lifescience-ltd-falls-209-3-key-factors-driving-the-weekly-decline-4237985",
        "imagepath": "",
        "date": "2026-10-25 14:00:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Oct 19:</strong> Stock surged to upper circuit at Rs.11.07 (+4.93%)</p>\n                    <p><strong>Oct 21:</strong> Another upper circuit hit at Rs.11.61 (+4.97%)</p>\n                    <p><strong>Oct 23:</strong> Shares hit lower circuit amid heavy selling, closing at Rs.10.33 (-4.17%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.10.55</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.10.33</div><div class=\"stat-change negative\">-2.09%</div></div>\n                    <div cl..."
      },
      {
        "title": "Nectar Lifescience Ltd Locks at Upper Circuit With 4.93% Gain — Buyers Queue, Sellers Absent",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nectar-lifescience-ltd-surges-to-upper-circuit-amid-strong-buying-pressure-4229943",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NectarLifescien_stocks_hitting_upper_circuit_4229943.png",
        "date": "2026-10-19 10:00:10",
        "description": "At Rs 11.06, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Nectar Lifescience Ltd locked at its upper circuit of 4.93% on 19 Oct 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Nectar Lifescience Ltd Locks at Upper Circuit With 4.98% Gain — Buyers Queue, Sellers Absent",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nectar-lifescience-ltd-surges-to-upper-circuit-amid-strong-buying-pressure-4227911",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NectarLifescien_stocks_hitting_upper_circuit_4227911.png",
        "date": "2026-10-16 11:00:10",
        "description": "At Rs 10.54, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Nectar Lifescience Ltd locked at its upper circuit of 4.98% on 15 Oct 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Nectar Lifescience Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/nectar-lifescience-ltd-is-rated-strong-sell-4227762",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NectarLifescien_mojoScore_4227762.png",
        "date": "2026-10-16 10:10:25",
        "description": "Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 October 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Nectar Lifescience Ltd Falls 4.16%: 2 Key Circuit Events Shape the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nectar-lifescience-ltd-falls-416-2-key-circuit-events-shape-the-week-4221925",
        "imagepath": "",
        "date": "2026-10-11 13:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>5 Oct:</strong> Week opens at ₹10.57</p>\n                    <p><strong>6 Oct:</strong> Hits upper circuit amid strong buying pressure (₹11.00)</p>\n                    <p><strong>7 Oct:</strong> Sharp correction with 3.90% decline (₹10.60)</p>\n                    <p><strong>8 Oct:</strong> Continued weakness, down 1.13% (₹10.48)</p>\n                    <p><strong>9 Oct:</strong> Hits lower circuit amid heavy selling pressure (₹10.13)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.10.57</div></div>\n                    <div class=\"stat-item\"><div class=\"s..."
      },
      {
        "title": "Nectar Lifescience Ltd Locks at Lower Circuit With 2.75% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/nectar-lifescience-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4220534",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/NectarLifescien_stocks_hitting_lower_circuit_4220534.png",
        "date": "2026-10-09 15:00:07",
        "description": "At Rs 10.03, sellers were still queuing — but there were no buyers willing to take the other side. Nectar Lifescience Ltd locked at its lower circuit of 2.75% on 9 Oct 2026, with unfilled sell orders and a frozen price."
      }
    ],
    "total": 66,
    "sid": "216478",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/nectar-lifescience-216478"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Nov-2026",
      "details": "Nectar Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Results For Quarter And Half Year Ended September 30 2026.",
      "datetime": "14-Nov-2026",
      "details": "Please find attached herewith Results For Quarter And Half Year Ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Financial Result And Other Business Matters",
      "datetime": "06-Nov-2026",
      "details": "Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve unaudited financial results for the period ended September 30 2026 and other business matters",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nectar Lifescience Ltd has declared <strong>5%</strong> dividend, ex-date: 11 Sep 20",
          "dt": "2020-09-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Nectar Lifescience Ltd has announced <strong>1:10</strong> stock split, ex-date: 12 Nov 08",
          "dt": "2008-11-12",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-Nov-2026 | Source : BSE

Nectar Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication

Results For Quarter And Half Year Ended September 30 2026.

14-Nov-2026 | Source : BSE

Please find attached herewith Results For Quarter And Half Year Ended September 30 2026.

Board Meeting Intimation for Financial Result And Other Business Matters

06-Nov-2026 | Source : BSE

Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve unaudited financial results for the period ended September 30 2026 and other business matters

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Nectar Lifescience Ltd has declared 5% dividend, ex-date: 11 Sep 20

stock-summary
SPLITS

Nectar Lifescience Ltd has announced 1:10 stock split, ex-date: 12 Nov 08

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available